🇺🇸 FDA
Patent

US 11260073

Compounds and methods for modulating C90RF72

granted A61KA61K31/7115A61K31/712

Quick answer

US patent 11260073 (Compounds and methods for modulating C90RF72) held by The Board of Regents of the University of Texas System expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/7115, A61K31/712, A61K31/7125, A61K48/0066